Log in to save to my catalogue

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturi...

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9757682

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors

About this item

Full title

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors

Publisher

US: Oxford University Press

Journal title

Journal of the Endocrine Society, 2023-02, Vol.7 (2), p.bvac181-bvac181

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Context
Tumor-induced osteomalacia (TIO) is one of the most common forms of acquired fibroblast growth factor 23 (FGF23)-related hypophosphatemia and is usually caused by phosphaturic mesenchymal tumors (PMTs). Although the complete resection of PMTs can cure TIO, preoperative localization of tumors by standard imaging modalities is...

Alternative Titles

Full title

Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9757682

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9757682

Other Identifiers

ISSN

2472-1972

E-ISSN

2472-1972

DOI

10.1210/jendso/bvac181

How to access this item